Liu showed that a high cytoplasmic FTH1 level correlates with a favorable prognosis, whereas nuclear FTH1 is an adverse indicator, in triple negative breast cancer patients [32]. The gene discussed is FTH1; the disease is triple-negative breast carcinoma.